Recent research and development of Antrodia cinnamomea
MC Lu, M El-Shazly, TY Wu, YC Du, TT Chang… - Pharmacology & …, 2013 - Elsevier
Medicinal mushrooms have attracted much attention recently owing to their potent
therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia …
therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia …
Lung cancer in women: emerging differences in epidemiology, biology, and therapy
L Thomas, LA Doyle, MJ Edelman - Chest, 2005 - Elsevier
Lung cancer is the major cause of cancer-related death in both men and women in the
United States. Emerging evidence indicates that there are differences in the pathogenesis …
United States. Emerging evidence indicates that there are differences in the pathogenesis …
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients
JL Pujol, O Molinier, W Ebert, JP Daures… - British Journal of …, 2004 - nature.com
The purpose of this study was to determine the prognostic significance of a high
pretreatment serum CYFRA 21-1 level (a cytokeratin 19 fragment) adjusted for the effects of …
pretreatment serum CYFRA 21-1 level (a cytokeratin 19 fragment) adjusted for the effects of …
[HTML][HTML] The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data
L Liu, X Shao, W Gao, J Bai, R Wang, P Huang… - Journal of Thoracic …, 2010 - Elsevier
Introduction Human epidermal growth factor receptor 2 (HER2) is regarded as a poor
prognostic factor in many tumors. Conflicting data in many literatures were reported about …
prognostic factor in many tumors. Conflicting data in many literatures were reported about …
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature
AP Meert, B Martin, M Paesmans, T Berghmans… - British journal of …, 2003 - nature.com
C-erbB-2 prognostic value for survival in patients with lung cancer remains controversial. We
performed a systematic review of the literature to clarify its impact. Studies were identified by …
performed a systematic review of the literature to clarify its impact. Studies were identified by …
Diagnostic relevance of circulating biomarkers in patients with lung cancer
R Molina, S Holdenrieder, JM Auge… - Cancer …, 2010 - content.iospress.com
Differential diagnosis of suspicious lung masses is essential for the selection of the
appropriate therapy strategy. While non-small cell lung cancer (NSCLC) in early stages and …
appropriate therapy strategy. While non-small cell lung cancer (NSCLC) in early stages and …
Association of HER‐2 overexpression with prognosis in nonsmall cell lung carcinoma: a metaanalysis
H Nakamura, N Kawasaki, M Taguchi, K Kabasawa - Cancer, 2005 - Wiley Online Library
BACKGROUND Prognostic implications of overexpression of the HER‐2 gene in nonsmall
cell lung carcinoma (NSCLC) are a matter of controversy. Many conflicting results have been …
cell lung carcinoma (NSCLC) are a matter of controversy. Many conflicting results have been …
Serum biomarker profiles as diagnostic tools in lung cancer
BM Nolen, CJ Langmead, S Choi… - Cancer …, 2012 - content.iospress.com
Background: Computed tomography (CT) scanning has emerged as an effective means of
early detection for lung cancer. Despite marked improvement over earlier methodologies …
early detection for lung cancer. Despite marked improvement over earlier methodologies …
Therapeutic HER2/Neu DNA vaccine inhibits mouse tumor naturally overexpressing endogenous neu
CC Lin, CW Chou, AL Shiau, CF Tu, TM Ko, YL Chen… - Molecular Therapy, 2004 - cell.com
The therapeutic efficacy of HER2/c-erbB-2/neu DNA immunization on mouse tumor cells
expressing exogenous human or rat p185 neu but not on mouse tumor cells naturally …
expressing exogenous human or rat p185 neu but not on mouse tumor cells naturally …
Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progression
I Osman, M Mikhail, B Shuch, M Clute, CD Cheli… - The Journal of …, 2005 - Elsevier
PURPOSE: We determined the association between serum levels of shed Her-2/neu protein
and disease progression in men with prostate cancer. MATERIALS AND METHODS: Serum …
and disease progression in men with prostate cancer. MATERIALS AND METHODS: Serum …